Carbon Biosciences

Lexington, United States

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

$38.0M raised

Jun 2022

Series A

Biotechnology Product Research Therapeutics

Top Investors

Longwood Fund UTokyo Innovation Platform DHVC Agent Capital Cystic Fibrosis Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Carbon Biosciences

How much funding has Carbon Biosciences raised?

Carbon Biosciences has raised $38.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.

Who are Carbon Biosciences's investors?

Carbon Biosciences's investors include Longwood Fund, UTokyo Innovation Platform, DHVC, Agent Capital, Cystic Fibrosis Foundation.

Where is Carbon Biosciences headquartered?

Carbon Biosciences is headquartered in Lexington, United States.

What does Carbon Biosciences do?

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

What stage is Carbon Biosciences at?

Carbon Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 21, 2022.

MLA

"Carbon Biosciences — Funding & Investors." VCBacked, June 21, 2022, https://www.vcbacked.co/company/carbon-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2022). Carbon Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/carbon-biosciences

Wikipedia (cite web)

{{cite web |title=Carbon Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/carbon-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 21, 2022.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K